CODX vs OMC · rev $3.9M vs rev $15.69B
Co-Diagnostics, Inc. Common Stock (CODX) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported OMC revenue for 2024-12-31 was $15.69B. Net income was $1.57B. Revenue was up 6.8% from 2023-12-31 to 2024-12-31. OMC currently screens at market cap $21.75B.
CODX currently screens at market cap $31.4M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the CODX and OMC stock pages for the full models.
Not investment advice.